Trial record 40 of 150 for:    fibromyalgia | Open Studies

Cross-sectional Study of Fibromyalgia

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Sponsor:
Information provided by (Responsible Party):
Juan Jiao, Guang'anmen Hospital of China Academy of Chinese Medical Sciences
ClinicalTrials.gov Identifier:
NCT02449395
First received: May 2, 2015
Last updated: May 20, 2015
Last verified: May 2015
  Purpose

This study is designed to collect data on precipitating factors, diagnosis, morbidity, therapy, quality of life, and symptom severity, etc. informations in patients with fibromyalgia.


Condition
Fibromyalgia

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: A Cross-sectional Study of Fibromyalgia in Beijing

Resource links provided by NLM:


Further study details as provided by Guang'anmen Hospital of China Academy of Chinese Medical Sciences:

Primary Outcome Measures:
  • Fibromyalgia symptoms severity as measured by Fibromyalgia Impact Questionnaire (FIQ) [ Time Frame: up to 1 week ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • QOL as measured by Short Form-36 Health Status Questionnaire (SF-36) [ Time Frame: up to 1 week ] [ Designated as safety issue: No ]
  • Pain scores as measured by Numerical rating scale (NRS) [ Time Frame: up to 1 week ] [ Designated as safety issue: No ]
  • Fatigue scores as measured by Multidimensional Assessment Fatigue (MAF) [ Time Frame: up to 1 week ] [ Designated as safety issue: No ]
  • Depression scores as measured by Beck depression inventory (BDI) [ Time Frame: up to 1 week ] [ Designated as safety issue: No ]
  • Stress scores as measured by Perceived Stress Scale (PSS) [ Time Frame: up to 1 week ] [ Designated as safety issue: No ]
  • Sleep scores as measured by Pittsburgh sleep quality index (PSQI) [ Time Frame: up to 1 week ] [ Designated as safety issue: No ]

Estimated Enrollment: 500
Study Start Date: April 2015
Estimated Study Completion Date: November 2018
Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)
Detailed Description:

Patients fulfilling 1990 or 2010 ACR criterion for fibromyalgia will be recruited in Fibromyalgia outpatient service which is belonged to the Department of Rheumatism. Except collecting patients' demographic and social characteristic informations, rheumatologist also carry out a comprehensive evaluation including patient current history, current medication use, and tender point examination for a diagnosis or confirmation of fibromyalgia and treatment recommendations. Patients with fibromyalgia will be asked to fill a set of questionnaires to evaluate their quality of life, symptoms severity, quality of sleep and emotion. The study will be conducted in Beijing, China.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients fulfilling 1990 or 2010 ACR criterion for fibromyalgia be seen in the Fibromyalgia Outpatient Service which belonged to the Department of Rheumatism, Guang'anmen Hospital, Beijing China.

Criteria

Inclusion Criteria:

  • Age 18 years or older.
  • Fulfills the American College of Rheumatology (ACR) 1990 classification criteria for Fibromyalgia.
  • Fulfills the American College of Rheumatology (ACR) 2010 classification criteria for Fibromyalgia.

Exclusion Criteria:

  • Don't fulfill any classification criterions for Fibromyalgia.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02449395

Contacts
Contact: Juan Jiao, M.D.,PhD 010-88001060 jiao.juan@hotmail.com
Contact: Yayun Zhao, M.M. +86 010-88001060 tobeornottobe2014@126.com

Locations
China, Beijing
Guang'anmen Hospital of China Academy of Chinese Medical Sciences Recruiting
Beijing, Beijing, China, 100053
Contact: Juan Jiao, M.D.,PhD    +86 010-88001060    jiao.juan@hotmail.com   
Contact: Yayun Zhao, M.M.    +86 010-88001060    tobeornottobe2014@126.com   
Sponsors and Collaborators
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Investigators
Principal Investigator: Juan Jiao, M.D.,PhD Guang'anmen Hospital of China Academy of Chinese Medical Sciences
  More Information

No publications provided

Responsible Party: Juan Jiao, attending physician, Guang'anmen Hospital of China Academy of Chinese Medical Sciences
ClinicalTrials.gov Identifier: NCT02449395     History of Changes
Other Study ID Numbers: 39301
Study First Received: May 2, 2015
Last Updated: May 20, 2015
Health Authority: China: State Administration of Traditional Chinese Medicine of the People's Republic of China

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on September 02, 2015